Cover image of the article: The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma

Image Credit:Hepat Mon

The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma

Authors

Olfat Hammam1, Ola Mahmoud2,*, Manal Zahran2, Sohair Aly3, Karim Hosny4, Amira Helmy5, Amgad Anas6

Abstract

Background:

The Fas receptor/ligand system including soluble forms is the most important apoptotic initiator in the liver. Dysregulation of this pathway may contribute to abnormal cell proliferation and cell death and is regarded as one of the mechanisms preventing the immune system from rejecting the tumor cells.

Objectives:

To analyze the role of Fas system Fas/ Fas ligand (Fas/ FasL) in the multi-step process of hepatic fibrosis/carcinogenesis, and to use of the serum markers as possible candidate biomarkers for early detection of hepatocellular carcinoma (HCC).

Patients and Methods:

Ninety patients were enrolled: 30 cases of chronic hepatitis C (CHC) without cirrhosis, 30 cases of CHC with liver cirrhosis, and 30 cases of HCC and hepatitis V virus (HCV) infection. Ten wedge liver biopsies, taken during laparoscopic cholecystectomy, were served as normal controls. Serum soluble Fas (sFas) levels were measured using ELISA technique; Fas and FasL proteins were detected in hepatic tissue by indirect Immuno-histochemical technique (IHC); electron microscopic (EM) and immune electron microscopic examinations were performed for detection of Fas expression on lymphocytes.

Results:

Hepatic expression of both Fas and FasL as well as expression of Fas on separated lymphocytes were significantly increased in the diseased groups (P < 0. 01) compared to the control specimens. The highest expression was noticed in CHC specimens, particularly with the necro-inflammatory activity and advancement of the fibrosis. The sFas in cirrhotic patients and HCC were significantly higher than that in normal controls and CHC without cirrhosis group (P < 0.01).

Conclusions:

Apoptosis and the Fas system were significantly involved in the process of converting liver cirrhosis into hepatocellular carcinoma. Down-regulation of Fas expression, up regulation of FasL expression in hepatocytes, and elevation of serum sFas levels were important in tumor evasion from immune surveillance, and in hepatic carcinogenesis.

Highlights

How to Cite:Hammam O, Mahmoud O, Zahran M, Aly S, Hosny K, et al. The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma. Hepat Mon. 2012;12(11):6132. doi: https://doi.org/10.5812/hepatmon.6132

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

10
Oct
2015
FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection

Asadollah Mohammadi,
Nader Tajik,
Alireza Shah-Hosseini,
Seyed Moayed Alavian,
Zohreh Sharifi,
Lida Jarahi

Mohammadi A, Tajik N, Shah-Hosseini A, Alavian SM, Sharifi Z, et al. FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection. Hepat Mon. 2015;15(10):e26490. doi: https://doi.org/10.5812/hepatmon.26490

24
Sep
2014
Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma

Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma

Shawky A Fouad,
Nehal H Elsaaid,
Nagwa A Mohamed,
Osama M Abutaleb

Fouad SA, Elsaaid NH, Mohamed NA, Abutaleb OM. Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma. Hepat Mon. 2014;14(9):e19346. doi: https://doi.org/10.5812/hepatmon.19346

31
Dec
2006
Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus

Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus

Ali Karami,
Seyed Moayed Alavian,
Ali Najafi,
Mohammad Javad Hosseini

Karami A, Alavian S, Najafi A, Hosseini M. Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus. Hepat Mon. 2006;6(2):. doi:

30
Sep
2008
Assessment of Treg Cells CD4(+)CD25(+) in Chronic Cirrhotic Liver Disease and Hepatocellular Carcinoma Egyptian Patients

Assessment of Treg Cells CD4(+)CD25(+) in Chronic Cirrhotic Liver Disease and Hepatocellular Carcinoma Egyptian Patients

Maha A. El Bassuoni,
Mones A. Obada,
Tarek Korah,
Sawsan El Sayed

El Bassuoni M, Obada M, Korah T, Sayed S. Assessment of Treg Cells CD4(+)CD25(+) in Chronic Cirrhotic Liver Disease and Hepatocellular Carcinoma Egyptian Patients. Hepat Mon. 2008;8(3):. doi:

29
Dec
2015
Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis

Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis

Wenli Sai,
Li Wang,
Wenjie Zheng,
Junling Yang,
Liuhong Pan,
Yin Cai
,et al.

Sai W, Wang L, Zheng W, Yang J, Pan L, et al. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis. Hepat Mon. 2015;15(12):e32918. doi: https://doi.org/10.5812/hepatmon.32918

More by these authors

Olfat HammamPubMedScholar
Ola MahmoudPubMedScholar
Manal ZahranPubMedScholar
Sohair AlyPubMedScholar
Karim HosnyPubMedScholar
Amira HelmyPubMedScholar
Amgad AnasPubMedScholar
Share
Cited by
Metrics
Indexed in